A Study of the Pharmacokinetic Interaction Between Pirfenidone and BMS-986278 in Healthy Participants
Status:
Completed
Trial end date:
2019-07-30
Target enrollment:
Participant gender:
Summary
The main objectives of this study are to characterize the PK of BMS-986278 after
administration of a single dose of BMS-986278 alone or in combination with pirfenidone, as
well as to characterize the PK of pirfenidone after administration of a single dose of
pirfenidone alone or in combination with BMS-986278